EKG vs. CEFS

In the year-to-date period, EKG achieves a 0.54% return, which is significantly lower than CEFS's 5.35% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

EKG has a 0.65% expense ratio, which is lower than CEFS's 3.80% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Saba Closed-End Funds ETF (CEFS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EKG Sharpe Ratio is 0.30, which is lower than the CEFS Sharpe Ratio of 1.15. The chart below compares the historical Sharpe Ratios of EKG and CEFS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

EKG has not paid dividends to shareholders, while CEFS's dividend yield for the trailing twelve months is around 8.62%.

The maximum EKG drawdown since its inception was -43.82%, which is greater than CEFS's maximum drawdown of -38.99%. Use the drawdown chart below to compare losses from any high point for EKG and CEFS.

First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) has a higher volatility of 7.45% compared to Saba Closed-End Funds ETF (CEFS) at 2.78%. This indicates that EKG's price experiences larger fluctuations and is considered to be riskier than CEFS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.